FOCAL ONSET SEIZURES
Clinical trials for FOCAL ONSET SEIZURES explained in plain language.
Never miss a new study
Get alerted when new FOCAL ONSET SEIZURES trials appear
Sign up with your email to follow new studies for FOCAL ONSET SEIZURES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New epilepsy drug shows promise in final stage trial
Disease control CompletedThis Phase 3 trial tested a drug called XEN1101 (azetukalner) in 380 adults with focal-onset seizures that were not well-controlled by other medications. Participants took either XEN1101 or a placebo alongside their usual seizure drugs. The study measured whether XEN1101 reduced …
Matched conditions: FOCAL ONSET SEIZURES
Phase: PHASE3 • Sponsor: Xenon Pharmaceuticals Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
New pill RAP-219 tested for stubborn seizures
Disease control CompletedThis study tested an investigational drug called RAP-219 in 30 adults with refractory focal epilepsy—seizures that don't respond well to current treatments. Participants took RAP-219 tablets to see if it safely reduces seizure frequency. The trial is now complete, and results wil…
Matched conditions: FOCAL ONSET SEIZURES
Phase: PHASE2 • Sponsor: Rapport Therapeutics Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC